Finally, to determine whether the reduction in CD226‐expressing‐cells is related to the shedding of this co‐stimulatory molecule, we quantified soluble CD226 concentrations in the plasma of CLL patients across varying Rai stages. This evidence concerns the gene CD226 and B-cell chronic lymphocytic leukemia.